Bhutan vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received a 3rd dose of
Proportion of the target population who received a 3rd dose of over time
- Bhutan
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
How they compare
Bhutan currently reports 98.0% against 84.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 14.0%.
That makes Bhutan's figure about 1.2 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ahead.
Bhutan ranks 7th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th of 157 countries.
Across the 2 decades both report, Bhutan averaged higher in 1 and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) in 1.
Head to head by decade
| Decade | Bhutan | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.0% | 85.0% | 59.0% | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) |
| 2020s | 95.8% | 83.6% | 12.2% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Bhutan or Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Bhutan, at 98.0% against 84.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Bhutan and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 14.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 6 years are reported by both, from 2019 to 2024.
- How do Bhutan and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank globally for proportion of the target population who received a 3rd dose of?
- Bhutan ranks 7th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.